Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma [Phase 2]
BRAZAN is a Phase 2 randomized trial evaluating induction with Bendamustine, Rituximab, Cytarabine plus Zanubrutinib, followed by Zanubrutin…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL [Phase 1]
A Phase 1 study evaluating pembrolizumab in combination with chemotherapy for newly diagnosed Primary Central Nervous System Lymphoma is cur…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care [NA]
This clinical trial update describes a University of Miami-sponsored study evaluating how Leukemia & Lymphoma Society services affect patien…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating the safety and pharmacokinetics of eflapegrastim in pediatric patients with solid tumors or lymphoma und…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma [Phase 1, Phase 2]
This is a pediatric and young adult Phase 1/2 clinical trial evaluating a CD22-directed CAR-T cell therapy for relapsed or refractory leukem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
The study investigates cachexia frequency in ambulatory cancer patients and the psychological burden on patients and their primary caregiver…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases
Recruiting for a national longitudinal cohort study of hematological diseases sponsored by the Institute of Hematology & Blood Diseases Hosp…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial comparing GEO-CM04S1 vaccine to an mRNA SARS-CoV-2 vaccine in patients with hematologic malignancies; the study is cu…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Pediatric PET/MR Image Registry
A pediatric PET/MR image registry is currently recruiting to collect imaging data for soft tissue sarcoma, lymphoma, and osteosarcoma.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Vaccine Responses in Patients With B Cell Malignancies [Phase 4]
A Phase 4 clinical trial is evaluating vaccine responses in patients with B cell malignancies, including lymphoma, and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma [Phase 1, Phase 2]
A Phase 1b/2 trial evaluating intravenous brincidofovir in relapsed or refractory lymphoma, including extranodal NK/T-cell lymphoma (ENKL), …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors [NA]
Clinical trial update describing a mindfulness intervention study for childhood cancer survivors aimed at improving health activation, copin…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial evaluating reduced-dose post-transplant cyclophosphamide as GVHD prophylaxis in HLA-mismatched unrelated donor periph…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy [NA]
Clinical Trial Update describes a recruiting study at the University of Utah evaluating multimodal telerehabilitation for patients undergoin…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma [Phase 1]
Phase 1 trial evaluating an in vivo CAR-T therapy targeting CD19 and BAFF-R for relapsed/refractory B-cell acute lymphoblastic leukemia and …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) [NA]
Completed clinical trial PREPARE evaluated a geriatric intervention in the treatment of older cancer patients. The update does not include t…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 dose-finding and dose-expansion study of OSE-279 in adults with advanced solid tumors or ly…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors [NA]
Duke University is recruiting for a study on symptom management and transitioning to engagement with post-treatment care for adolescent and …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) [Phase 1]
Phase 1 clinical trial evaluating CD8 PET imaging as a biomarker of immune response to stereotactic body radiation therapy in patients with …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics [NA]
This entry reports a recruiting trial at UNC Lineberger Comprehensive Cancer Center evaluating a decision-support tool for adults with hemat…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy [EARLY_Phase 1]
An early-phase clinical trial from the University of Oklahoma is investigating neuromodulation to reduce cardiovascular risks associated wit…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study [NA]
This update reports completion of the INSPIRE-AYA clinical trial, an interactive survivorship program aimed at improving healthcare resource…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating a CD70-directed CAR T-cell therapy for pediatric hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center is recruiting families for genetic studies of familial lymphoproliferative disorders, including lymph…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
This clinical trial update indicates ongoing recruitment for a study documenting treatment outcomes and responses in lymphoma-associated hem…